CN208114809U - A kind of band opens the liquid liquid double-chamber transfusion bag on side - Google Patents
A kind of band opens the liquid liquid double-chamber transfusion bag on side Download PDFInfo
- Publication number
- CN208114809U CN208114809U CN201720732921.6U CN201720732921U CN208114809U CN 208114809 U CN208114809 U CN 208114809U CN 201720732921 U CN201720732921 U CN 201720732921U CN 208114809 U CN208114809 U CN 208114809U
- Authority
- CN
- China
- Prior art keywords
- chamber
- liquid
- bag body
- bag
- band
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000007788 liquid Substances 0.000 title claims abstract description 36
- 239000007924 injection Substances 0.000 claims abstract description 14
- 238000002347 injection Methods 0.000 claims abstract description 14
- 238000003466 welding Methods 0.000 claims abstract description 12
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 claims abstract description 11
- -1 Amino Acid Compound Chemical class 0.000 claims abstract description 8
- 239000012530 fluid Substances 0.000 claims abstract description 6
- 230000004888 barrier function Effects 0.000 claims description 11
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 10
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 6
- 239000007789 gas Substances 0.000 claims description 6
- 239000001301 oxygen Substances 0.000 claims description 6
- 229910052760 oxygen Inorganic materials 0.000 claims description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 5
- 239000001569 carbon dioxide Substances 0.000 claims description 5
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 5
- 239000005030 aluminium foil Substances 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- 229910052757 nitrogen Inorganic materials 0.000 claims description 2
- 239000004033 plastic Substances 0.000 claims description 2
- 229920003023 plastic Polymers 0.000 claims description 2
- 208000012260 Accidental injury Diseases 0.000 abstract description 2
- 208000014674 injury Diseases 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 10
- 229940090044 injection Drugs 0.000 description 10
- 239000000243 solution Substances 0.000 description 10
- HJCMDXDYPOUFDY-WHFBIAKZSA-N Ala-Gln Chemical compound C[C@H](N)C(=O)N[C@H](C(O)=O)CCC(N)=O HJCMDXDYPOUFDY-WHFBIAKZSA-N 0.000 description 8
- 229960002648 alanylglutamine Drugs 0.000 description 8
- 108010044940 alanylglutamine Proteins 0.000 description 8
- 238000001802 infusion Methods 0.000 description 7
- 150000001413 amino acids Chemical class 0.000 description 6
- 229940079593 drug Drugs 0.000 description 6
- 239000003814 drug Substances 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229940121657 clinical drug Drugs 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000005022 packaging material Substances 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000790917 Dioxys <bee> Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000008156 Ringer's lactate solution Substances 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- BPKIGYQJPYCAOW-FFJTTWKXSA-I calcium;potassium;disodium;(2s)-2-hydroxypropanoate;dichloride;dihydroxide;hydrate Chemical compound O.[OH-].[OH-].[Na+].[Na+].[Cl-].[Cl-].[K+].[Ca+2].C[C@H](O)C([O-])=O BPKIGYQJPYCAOW-FFJTTWKXSA-I 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229940093181 glucose injection Drugs 0.000 description 1
- 239000008155 medical solution Substances 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- WGYKZJWCGVVSQN-UHFFFAOYSA-N mono-n-propyl amine Natural products CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000002504 physiological saline solution Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000008354 sodium chloride injection Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
The utility model discloses the liquid liquid double-chamber transfusion bags that a kind of band opens side comprising the easy unlatching band in bag body and bag body, the bag body are divided into large capacity chamber and low capacity chamber by weak welding rod, and the easy unlatching band is set to bag body bottom side.The utility model can facilitate clinical staff is scientific and reasonable to use alanimamides glutamine injection and Amino Acid Compound Injection, save therapeutic time, workload of the nurse is reduced, the accidental injury of the pollution and bottle plug puncture unit of medical fluid to medical staff is avoided, strives for the quality time for clinical emergency treatment.
Description
Technical field
The utility model relates to the liquid liquid double-chamber transfusion bags that a kind of band opens side, and in particular to the third of a kind of band unlatching side
Glutamine glutamine injection and Amino Acid Compound Injection liquid liquid double-chamber transfusion bag, belong to medical packaging material field.
Background technique
In recent years, medical research shows that the shortage of parenteral nutrient solution (such as alanyl glutamine) can cause a variety of diseases
Disease, being replenished in time has extensive and important influence to the various functions of body.Japan disappears as treatment first within 1979
The drug for changing tract disease is launched, for treating gastric ulcer, chronic gastritis etc..In developed country, glutamine is considered as
The basis in nutrient formulation that sportsman improves results, currently, glutamine has been largely used to the movement for the treatment of sportsman
Syndrome or post exercise fatigue recovery.Since glutamine has unstability, so its solution was not only thermo-labile, but also intolerant to storage
It deposits.Solubility is high in aqueous solution for alanyl-glutamine, and resistant against high temperatures disinfection still keeps stable in room temperature lower 2 years, in human body
Interior to resolve into glutamine and propylamine amide rapidly, alanyl-glutamine preparation can satisfy the above demand.
Since alanyl-glutamine injection is a kind of highly concentrated solution, not directly it is transfused, it need to be molten with other carriers
Liquid mixing infusion.Currently, clinical staff glucose injection, sodium chloride injection mostly accustomed to using etc. and its compatibility, but face
Bed research discovery alanyl glutamine and physiological saline, Dextrose and Sodium Chloride Inj., lactated Ringer's injection compatibility 6 are small
When, content has reduction, and compatibility difference is all not so good as good with amino acid effect.
Before infusion, the infusion with compatible amino acid solution or containing amino acid is mixed, then with carrier solution
It is transfused together, could preferably play effect.And given simultaneously with other amino acid, glutamine can be preferably protected,
Make it that can not be converted into other amino acid forms, to play its due effect.The alanyl-glutamine of 1 volume is injected
Liquid should be mixed with the carrier solution of at least 5 volumes.
Infusion packaging material development course is glass infusion bottle, polypropylene transfusion bottle, non-PVC single chamber soft bag, bis- (more) rooms non-PVC
Soft bag.To guarantee alanyl-glutamine injection and the solution compatibility containing amino acid, solvent volume reaches requirement, prevents to match
5 unreasonable situations facilitate clinical use, reduce Linchuan medical staff and mismatch and using other diluent configuring conditions
Occur, the use of specification alanyl-glutamine injection, promotes clinical rational drug use, improves data for clinical drug use, this is practical
A kind of band of new design opens the liquid liquid double-chamber transfusion bag on side.
Summary of the invention
The purpose of this utility model is that clinical staff is scientific and reasonable for convenience to be infused using alanimamides glutamine
Penetrate liquid and Amino Acid Compound Injection, save therapeutic time, facilitate operation, reduction workload of the nurse, avoid medical fluid pollution and
Accidental injury of the bottle plug puncture unit to medical staff strives for the quality time for clinical emergency treatment.
To achieve the above object, the technical solution of the utility model is as follows：
A kind of band opens the liquid liquid double-chamber transfusion bag on side, including the easy unlatching band in bag body and bag body, the bag body quilt
Weak welding rod is divided into large capacity chamber and low capacity chamber, and the easy unlatching band is set to bag body bottom side.
Preferably, the large capacity chamber is at least 3 times of low capacity chamber.
Preferably, the volume of the large capacity chamber is 250ml-1000ml, and the volume of the low capacity chamber is 100-
250ml。
Preferably, the width of the weak welding rod is 1.5cm-2.0cm, and dynamics needed for opening weak welding rod is 3-10N.
Preferably, the bag body is wrapped up by an outer barrier bag, is formed double shielding with bag body, is prevented oxygen, nitrogen, dioxy
Change carbon or other gases enter medical fluid.
Preferably, content cavity is equipped between the bag body and outer barrier bag.
Preferably, one or both of oxygen indicator and deoxidier are housed in the content cavity.
Preferably, the carbon dioxide transit dose of the outer barrier bag is 3.0-20.0cm3/m2For 24 hours, the transmission of vapor
Amount is 1.0-5.0g/m2·24h。
Preferably, Amino Acid Compound Injection is housed in the large-capacity chamber room, the third ammonia is housed in the small-capacity chamber room
Amide Gln injection.
Preferably, the material of the outer barrier bag is plastics or aluminium foil.
Preferably, the bag body bottom is additionally provided with two hanging holes.
The original design intention of the utility model is the generation of two kinds of clinical drug compatibility mistakes in order to prevent, reduces the dirt for matching liquid
Probability is contaminated, and its implementation is different drugs to be packaged individually in different chambers, forms chamber independent, chamber
Between connected by certain mode, be not connected to mutually between each chamber when being not used, by rotation when use, squeeze, fracture etc. square
Formula can be such that the drug of each chamber is connected to, and realize i.e. with function i.e..
Compared with the existing technology, the utility model tool has the advantage that：
The utility model meets clinically safety, requirement that is rapid, facilitating infusion treatment, is especially suitable for wartime infusion,
Conducive to the drug safety for guaranteeing the medical condition backward areas people, drug contamination is prevented.
Detailed description of the invention
Fig. 1 is the utility model overall structure diagram.
Description of symbols：1- bag body；2- easily opens band；The weak welding rod of 3-；4- large capacity chamber；5- low capacity chamber；6-
Outer barrier tape；7- content cavity；8- hanging hole.
Specific embodiment
Now in conjunction with implementation and attached drawing to the construction of the utility model, shape and the further details of explanation of feature.It should manage
Solution, the present embodiment is merely to illustrate the utility model, rather than limits the protection scope of the utility model.
A kind of band opens the liquid liquid double-chamber transfusion bag on side, including the easy unlatching band 2 in bag body 1 and bag body 1, the bag body
1 is divided into large capacity chamber 4 and low capacity chamber 5 by weak welding rod 3, and the easy unlatching band 2 is set to 1 bottom side of bag body, described
Bag body bottom is additionally provided with two hanging holes 8.
The volume of the large capacity chamber 4 is 250ml-1000ml, and the volume of the low capacity chamber 5 is 100-250ml,
Wherein the width of weak welding rod 3 is 1.5cm-2.0cm, and dynamics needed for opening weak welding rod 3 is 3-10N, in the large capacity chamber 4
Equipped with Amino Acid Compound Injection, the low capacity chamber 5 is provided with alanimamides glutamine injection.
The bag body 1 is wrapped up by the outer barrier bag 6 of an aluminium foil material, is formed double shielding with bag body 1, is prevented oxygen, nitrogen
Gas, carbon dioxide or other gases enter medical fluid, wherein content cavity 7, institute are equipped between the bag body 1 and outer barrier bag 6
State in content cavity 7 equipped with oxygen indicator and deoxidier, for monitor outer barrier bag 6 whether gas leakage, once gas leakage, deoxidation
Agent can absorb partial oxidation, prevents gas from entering bag body 1.
The carbon dioxide transit dose of the outer barrier bag 6 is 3.0-20.0cm3/m2For 24 hours, the transit dose of vapor is
1.0-5.0g/m2·24h。
When the utility model needs admixing medical solutions, band 2 first will be easily opened to side and inverts several circles, until weak welding rod 3 is disconnected
It splits, after medical fluid is sufficiently mixed, unclamps and easily open band 2, make its reinstatement.
The description of the utility model is merely illustrative above, and not restrictive, those skilled in the art should be managed
Solution can carry out many modifications, variation or equivalent within the spirit and scope that claim limits to it, but they will all fall
Enter in the protection scope of the utility model.
Claims (8)
1. the liquid liquid double-chamber transfusion bag that a kind of band opens side, which is characterized in that including the easy unlatching band in bag body and bag body, institute
It states bag body and large capacity chamber and low capacity chamber is divided by welding rod, the easy unlatching band is set to bag body bottom side；
Amino Acid Compound Injection is housed in the large-capacity chamber room, alanimamides glutamine is housed in the small-capacity chamber room
Injection；
The volume of the large capacity chamber is 250ml-1000ml, and the volume of the low capacity chamber is 100-250ml.
2. the liquid liquid double-chamber transfusion bag on band unlatching as described in claim 1 side, which is characterized in that the large capacity chamber is
At least 3 times of low capacity chamber.
3. the liquid liquid double-chamber transfusion bag on band unlatching as described in claim 1 side, which is characterized in that the width of the welding rod is
1.5cm-2.0cm, dynamics needed for opening welding rod are 3-10N.
4. as described in claim 1 with the liquid liquid double-chamber transfusion bag for opening side, which is characterized in that the bag body is by an extrernal resistance
Compartment package forms double shielding with bag body, prevents oxygen, nitrogen, carbon dioxide or other gases from entering medical fluid.
5. as claimed in claim 4 with the liquid liquid double-chamber transfusion bag for opening side, which is characterized in that the bag body and outer barrier
Content cavity is equipped between bag.
6. as claimed in claim 5 with the liquid liquid double-chamber transfusion bag for opening side, which is characterized in that in the content cavity
Equipped with one or both of oxygen indicator and deoxidier.
7. as the described in any item bands of claim 4-6 open the liquid liquid double-chamber transfusion bag on side, which is characterized in that the extrernal resistance
The carbon dioxide transit dose of compartment is 3.0-20.0cm3/m2For 24 hours, the transit dose of vapor is 1.0-5.0g/m2·24h。
8. as described in claim 1 with the liquid liquid double-chamber transfusion bag for opening side, which is characterized in that the material of the outer barrier bag
Matter is plastics or aluminium foil.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201720732921.6U CN208114809U (en) | 2017-06-22 | 2017-06-22 | A kind of band opens the liquid liquid double-chamber transfusion bag on side |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201720732921.6U CN208114809U (en) | 2017-06-22 | 2017-06-22 | A kind of band opens the liquid liquid double-chamber transfusion bag on side |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN208114809U true CN208114809U (en) | 2018-11-20 |
Family
ID=64208227
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201720732921.6U Active CN208114809U (en) | 2017-06-22 | 2017-06-22 | A kind of band opens the liquid liquid double-chamber transfusion bag on side |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN208114809U (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110680753A (en) * | 2019-10-24 | 2020-01-14 | 贵州省人民医院 | Preparation method of disposable intestine feeding device |
| WO2021043120A1 (en) * | 2019-09-05 | 2021-03-11 | 复旦大学附属中山医院 | Compound amino acid dipeptide injection and preparation method therefor and application thereof |
-
2017
- 2017-06-22 CN CN201720732921.6U patent/CN208114809U/en active Active
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2021043120A1 (en) * | 2019-09-05 | 2021-03-11 | 复旦大学附属中山医院 | Compound amino acid dipeptide injection and preparation method therefor and application thereof |
| CN110680753A (en) * | 2019-10-24 | 2020-01-14 | 贵州省人民医院 | Preparation method of disposable intestine feeding device |
| CN110680753B (en) * | 2019-10-24 | 2022-03-29 | 贵州省人民医院 | Preparation method of disposable intestine feeding device |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2985740T3 (en) | Infusion dosage form | |
| CN208114809U (en) | A kind of band opens the liquid liquid double-chamber transfusion bag on side | |
| CN104254345B (en) | There is the transfusion of the pH stability of enhancing under ethylene oxide sterilizing | |
| CN103432164A (en) | Peritoneal dialysis solution and preparation method thereof | |
| CA2528159C (en) | Aseptic combination preparation | |
| CN105748289B (en) | A kind of anti-pollution plastic ampoule dispenser | |
| CN2865677Y (en) | Immediate dispensing infusion soft bag | |
| JP4041171B2 (en) | Platelet preservation solution | |
| TW200835473A (en) | Multicompartment bag | |
| CN210114722U (en) | Single-dose or small-dose nasal spray device | |
| TWI220863B (en) | Multiple-chamber container reagent | |
| CN201189287Y (en) | Powder liquid double-chamber medicine bag | |
| JP7548901B2 (en) | Container for cardioplegic solution containing bicarbonate ion and method for producing same | |
| CN105213187A (en) | A kind of packaging of sodium bicarbonate injection | |
| CN105267034A (en) | Package of sodium bicarbonate injection | |
| CN207125897U (en) | A kind of infusion bottle with automatic flushing function | |
| CN203647772U (en) | Disposable oxygen dissolver | |
| CN204734721U (en) | Negative pressure type multi-layer polypropylene infusion bag | |
| CN211326891U (en) | Flushable tube double-chamber infusion device for offshore infusion | |
| TWI687245B (en) | Infusion cannula | |
| CN2824926Y (en) | Power-liquid isolated dual-chamber infusion bag | |
| CN202987814U (en) | Medicine packaging box | |
| CN102429860A (en) | Double-cavity bag-packaged cefpirome sulfate injection and preparation method thereof | |
| CN108451974A (en) | A kind of aspartic acid Multiple electrolytes injection and preparation method thereof | |
| WO2022246990A1 (en) | Salt-ozone ice medicine for injection and production thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GR01 | Patent grant | ||
| GR01 | Patent grant |